$BIAF

$2.83 +$0.03 (1.07%) Close

$BIAF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 8.1M shares outstanding

Who owns BIAF?

By type of holder

Institutions 9.6% Insiders 3.3% Everyone else 87.1%

Concentration Top 10 holders own 11.4%

Sabby Management, LLC 4.5% · Girgenti Steven 2.2%

Institutional ownership

9.6%

+6.6 pts vs last qtr

Institutional holders

+5 vs last qtr

Net shares bought

+536.8K

by institutions in Q2 2026

New / sold out

9 / 4

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Sabby Management, LLC NEW +365.6K
BlackRock, Inc. NEW +98.8K

Biggest sellers in Q2 2026

Schonfeld Strategic Advisors LLC SOLD OUT −24.4K
UBS Group AG −5.0K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for bioAffinity Technologies Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+325.8%

+325.83% a year

Each share's claim on the business

−76.5%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $1.66M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years1% 1–3 years0% Under 1 year99%

Quarterly turnover

123.4%

of institutional shares changed hands

Top 10 managers, median time held

1 quarter

Super Investors

Investment managers reporting BIAF on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
SM Sabby Management, LLC	365.6K	4.51%	NEW	Q2 '26	0.3%
Shares held by quarter Peak holding365.6K (Q2'26) Change over 8 quarters+365.6K Share of the company4.510% Sabby Management, LLC's full portfolio →
B BlackRock, Inc.	98.8K	1.22%	NEW	Q2 '26	0.0%
Shares held by quarter Peak holding98.8K (Q2'26) Change over 8 quarters+98.8K Share of the company1.220% BlackRock, Inc.'s full portfolio →

Sabby Management, LLC

365.6K

% of company

4.51%

Change vs last qtr

NEW

Held since

Q2 '26

BlackRock, Inc.

98.8K

% of company

1.22%

Change vs last qtr

NEW

Held since

Q2 '26

21 more super investors behind a free account

See every manager holding bioAffinity Technologies Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting BIAF on Form N-PORT; together they hold 1.5% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$46.9K	28.1K	0.35%	0.00%	May 31, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$45.1K	55.5K	0.69%	0.00%	June 30, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$46.9K

% of company

0.35%

% of the fund

0.00%

As of

May 31, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$45.1K

% of company

0.69%

% of the fund

0.00%

As of

June 30, 2026

6 more funds behind a free account

See every fund holding bioAffinity Technologies Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
GS Girgenti Steven Insider	181.5K	2.24%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company2.240% Girgenti Steven's insider activity →
ZM Zannes Maria Insider	46.7K	0.58%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.580% Zannes Maria's insider activity →

Girgenti Steven

Insider

181.5K

% of company

2.24%

Change vs last qtr

—

Held since

—

Zannes Maria

Insider

46.7K

% of company

0.58%

Change vs last qtr

—

Held since

—

4 more holders behind a free account

See every insider and 5%+ holder of bioAffinity Technologies Inc.

Comments